Safety and Efficacy of Long-term Sarilumab Treatment in Patients with Active Rheumatoid Arthritis: EXTEND and MONARCH Open Label Extension Studies

被引：0

作者：

Burmester, Gerd ^{[1
]}

Strand, Vibeke ^{[2
]}

Kivitz, Alan ^{[3
]}

Hu, Chih-Chi ^{[4
]}

Wang, Sheldon ^{[4
]}

van Hoogstraten, Hubert ^{[5
]}

Tao, Ray ^{[6
]}

Fleischmann, Roy ^{[7
,8
]}

机构：

[1] Charite Univ Med Berlin, Berlin, Germany

[2] Stanford Univ, Sch Med, Portola Valley, CA USA

[3] Altoona Ctr Clin Res, Duncansville, PA USA

[4] Sanofi Genzyme, Bridgewater, NJ USA

[5] Sanofi, Bridgewater, NJ USA

[6] Sanofi China R&D, Shanghai, Peoples R China

[7] Metroplex Clin Res Ctr, Dallas, TX USA

[8] Univ Texas Southwestern Med Ctr, Dallas, TX USA

来源：

ARTHRITIS & RHEUMATOLOGY | 2021年 / 73卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1690

引用

页码：3521 / 3525

页数：5

共 50 条

[1] Long-Term Safety and Efficacy of Olokizumab in Patients with Rheumatoid Arthritis - Results of an Open-Label Extension Study
Feist, Eugen
Nasonov, Evgeny
Luggen, Michael
Fatenejad, Saeed
Grishin, Sergey
Samsonov, Mikhail
Fleischmann, Roy
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 603 - 606
[2] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
Kivitz, Alan
Wells, Alvin F. F.
Vargas, Juan I. I.
Baraf, Herbert S. B.
Rischmueller, Maureen
Klaff, Justin
Khan, Nasser
Li, Yihan
Carter, Kyle
Friedman, Alan
Durez, Patrick
RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 901 - 915
[3] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
Alan Kivitz
Alvin F. Wells
Juan I. Vargas
Herbert S. B. Baraf
Maureen Rischmueller
Justin Klaff
Nasser Khan
Yihan Li
Kyle Carter
Alan Friedman
Patrick Durez
Rheumatology and Therapy, 2023, 10 : 901 - 915
[4] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
Kivitz, Alan
Wells, Alvin F.
Vargas, Juan I.
Baraf, Herbert S. B.
Rischmueller, Maureen
Klaff, Justin
Khan, Nasser
Li, Yihan
Carter, Kyle
Friedman, Alan
Durez, Patrick
RHEUMATOLOGY, 2023, 62
[5] LONG-TERM SAFETY AND EFFICACY OF UPADACITINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS: FINAL RESULTS FROM THE BALANCE-EXTEND OPEN-LABEL EXTENSION STUDY
Kivitz, A.
Wells, A. F.
Vargas, J. Ignacio
Baraf, H. S. B.
Rischmueller, M.
Klaff, J.
Khan, N.
Li, Y.
Carter, K.
Friedman, A.
Durez, P.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 620 - 621
[6] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
Cohen, Stanley
Pablos, Jose L.
Pavelka, Karel
Mueller, Gerard Anton
Matsumoto, Alan
Kivitz, Alan
Wang, Hui
Krishnan, Eswar
ARTHRITIS RESEARCH & THERAPY, 2019, 21 (1)
[7] An open-label extension study to demonstrate long-term safety and efficacy of ABP 501 in patients with rheumatoid arthritis
Stanley Cohen
Jose L. Pablos
Karel Pavelka
Gerard Anton Müller
Alan Matsumoto
Alan Kivitz
Hui Wang
Eswar Krishnan
Arthritis Research & Therapy, 21
[8] Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH openlabel extension
Burmester, Gerd R.
Strand, Vibeke
Rubbert-Roth, Andrea
Amital, Howard
Raskina, Tatiana
Gomez-Centeno, Antonio
Pena-Rossi, Claudia
Gervitz, Leon
Thangavelu, Karthinathan
St John, Gregory
Boklage, Susan
Genovese, Mark C.
RMD OPEN, 2019, 5 (02):
[9] Efficacy and safety of sarilumab in patients with active rheumatoid arthritis
McCarty, Delilah
Robinson, April
THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2018, 10 (03) : 61 - 67
[10] Safety and Efficacy of Baricitinib through 128 Weeks in an Open-Label, Long-Term Extension Study in Patients with Rheumatoid Arthritis
Keystone, Ed
Taylor, Peter
Genovese, Mark
Schlichting, Douglas
de la Torre, Inmaculada
Beattie, Scott
Rooney, Terence
JOURNAL OF RHEUMATOLOGY, 2015, 42 (07) : 1292 - 1292

← 1 2 3 4 5 →